These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7544276)

  • 41. IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo.
    Yoshimatsu M; Kitaura H; Fujimura Y; Eguchi T; Kohara H; Morita Y; Yoshida N
    Bone; 2009 Nov; 45(5):1010-6. PubMed ID: 19651258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.
    Michigami T; Shimizu N; Williams PJ; Niewolna M; Dallas SL; Mundy GR; Yoneda T
    Blood; 2000 Sep; 96(5):1953-60. PubMed ID: 10961900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enrichment of generated murine osteoclasts.
    Shioi A; Ross FP; Teitelbaum SL
    Calcif Tissue Int; 1994 Nov; 55(5):387-94. PubMed ID: 7532541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells.
    Kukita A; Kukita T; Hata K; Kurisu K; Kohashi O
    Bone Miner; 1993 Nov; 23(2):113-27. PubMed ID: 8305877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tartrate-resistant acid phosphatase is not an exclusive marker for mouse osteoclasts in cell culture.
    Modderman WE; Tuinenburg-Bol Raap AC; Nijweide PJ
    Bone; 1991; 12(2):81-7. PubMed ID: 2064844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adipogenesis in a myeloid supporting bone marrow stromal cell line.
    Gimble JM; Youkhana K; Hua X; Bass H; Medina K; Sullivan M; Greenberger J; Wang CS
    J Cell Biochem; 1992 Sep; 50(1):73-82. PubMed ID: 1339460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnesium deficiency results in an increased formation of osteoclasts.
    Belluci MM; Schoenmaker T; Rossa-Junior C; Orrico SR; de Vries TJ; Everts V
    J Nutr Biochem; 2013 Aug; 24(8):1488-98. PubMed ID: 23517915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
    Takeshita S; Kaji K; Kudo A
    J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic analysis of the ability of stromal cell lines derived from different murine adult tissues to support maintenance of hematopoietic stem cells in vitro.
    Rios M; Williams DA
    J Cell Physiol; 1990 Dec; 145(3):434-43. PubMed ID: 1703166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
    J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6).
    Sato T; Hakeda Y; Yamaguchi Y; Mano H; Tezuka K; Matsumoto K; Nakamura T; Mori Y; Yoshizawa K; Sumitani K
    J Cell Physiol; 1995 Jul; 164(1):197-204. PubMed ID: 7790391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF.
    Sells Galvin RJ; Gatlin CL; Horn JW; Fuson TR
    Biochem Biophys Res Commun; 1999 Nov; 265(1):233-9. PubMed ID: 10548519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone loss in regucalcin transgenic rats: enhancement of osteoclastic cell formation from bone marrow of rats with increasing age.
    Uchiyama S; Yamaguchi M
    Int J Mol Med; 2004 Sep; 14(3):451-5. PubMed ID: 15289899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The biological roles of the third component of complement in osteoclast formation.
    Sato T; Abe E; Jin CH; Hong MH; Katagiri T; Kinoshita T; Amizuka N; Ozawa H; Suda T
    Endocrinology; 1993 Jul; 133(1):397-404. PubMed ID: 8319587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of murine stromal cell clones established from bone marrow and spleen.
    Tsuji T; Ogasawara H; Aoki Y; Tsurumaki Y; Kodama H
    Leukemia; 1996 May; 10(5):803-12. PubMed ID: 8656675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells.
    Jimi E; Shuto T; Koga T
    Endocrinology; 1995 Feb; 136(2):808-11. PubMed ID: 7835314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor-I supports formation and activation of osteoclasts.
    Mochizuki H; Hakeda Y; Wakatsuki N; Usui N; Akashi S; Sato T; Tanaka K; Kumegawa M
    Endocrinology; 1992 Sep; 131(3):1075-80. PubMed ID: 1505451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
    Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
    Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells.
    Takahashi N; Udagawa N; Akatsu T; Tanaka H; Isogai Y; Suda T
    Endocrinology; 1991 Apr; 128(4):1792-6. PubMed ID: 2004603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.